Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated:  6/11/2011
Clinical Research Facility
mi
from
Anaheim, CA
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated: 6/11/2011
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated:  6/11/2011
Clinical Research Facility
mi
from
Fresno, CA
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated: 6/11/2011
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated:  6/11/2011
Clinical Research Facility
mi
from
La Jolla, CA
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated: 6/11/2011
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated:  6/11/2011
Clinical Research Facility
mi
from
Denver, CO
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated: 6/11/2011
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated:  6/11/2011
Clinical Research Facility
mi
from
Winter Park, FL
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated: 6/11/2011
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated:  6/11/2011
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated: 6/11/2011
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated:  6/11/2011
Clinical Research Facility
mi
from
Louisville, KY
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated: 6/11/2011
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated:  6/11/2011
Clinical Research Facility
mi
from
El Paso, TX
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
A Phase I/II, Double-Blind, Randomized, Placebo-Controlled, Dose Ranging Study of the Safety, Tolerance, Pharmacokinetics and Activity of HE3286 When Administered Orally to Patients With Active, Mild-to-Moderate Ulcerative Colitis
Status: Enrolling
Updated: 6/11/2011
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation
Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation
Status: Enrolling
Updated:  6/16/2011
Le Bonheur Children's Medical Center
mi
from
Memphis, TN
Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation
Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation
Status: Enrolling
Updated: 6/16/2011
Le Bonheur Children's Medical Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's Disease
Effect of Probiotic VSL#3 on Intestinal Permeability of Pediatric Patients With Crohn's Disease in Remission
Status: Enrolling
Updated:  6/21/2011
Children's Mercy Hospital
mi
from
Kansas City, MO
Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's Disease
Effect of Probiotic VSL#3 on Intestinal Permeability of Pediatric Patients With Crohn's Disease in Remission
Status: Enrolling
Updated: 6/21/2011
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Heart Function in Patients With Mitral Valve Disease
Mitigating the Mitochondrial Dysfunction and Apoptosis in Hypertrophied Left Atrium of Patients With Severe Mitral Valve Regurgitation Via Short-term Lovaza Treatment Prior to Surgery
Status: Enrolling
Updated:  6/21/2011
Brody School of Medicine
mi
from
Greenville, NC
Pilot Study of Lovaza (Omega 3 Fatty Acids) to Improve Heart Function in Patients With Mitral Valve Disease
Mitigating the Mitochondrial Dysfunction and Apoptosis in Hypertrophied Left Atrium of Patients With Severe Mitral Valve Regurgitation Via Short-term Lovaza Treatment Prior to Surgery
Status: Enrolling
Updated: 6/21/2011
Brody School of Medicine
mi
from
Greenville, NC
Click here to add this to my saved trials
The Use of Domperidone for Gastroparesis
Monitoring Study for the Use of Gastroparesis for Patient Who Have Failed Standard Therapy
Status: Enrolling
Updated:  6/22/2011
Allegiance Gastroenterology
mi
from
Jackson, MI
The Use of Domperidone for Gastroparesis
Monitoring Study for the Use of Gastroparesis for Patient Who Have Failed Standard Therapy
Status: Enrolling
Updated: 6/22/2011
Allegiance Gastroenterology
mi
from
Jackson, MI
Click here to add this to my saved trials
Impaired Wound Healing in Diabetic Foot Ulceration
Impaired Wound Healing in Diabetic Foot Ulceration
Status: Enrolling
Updated:  6/23/2011
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Impaired Wound Healing in Diabetic Foot Ulceration
Impaired Wound Healing in Diabetic Foot Ulceration
Status: Enrolling
Updated: 6/23/2011
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome: A Pilot Study
Status: Enrolling
Updated:  6/23/2011
Children's Hospital - Boston
mi
from
Boston, MA
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome: A Pilot Study
Status: Enrolling
Updated: 6/23/2011
Children's Hospital - Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome: A Pilot Study
Status: Enrolling
Updated:  6/23/2011
Children's Hospital of Michigan
mi
from
Detroit, MI
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome: A Pilot Study
Status: Enrolling
Updated: 6/23/2011
Children's Hospital of Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome: A Pilot Study
Status: Enrolling
Updated:  6/23/2011
William Beaumont Hospital-Royal Oak
mi
from
Royal Oak, MI
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome: A Pilot Study
Status: Enrolling
Updated: 6/23/2011
William Beaumont Hospital-Royal Oak
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis
Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis
Status: Enrolling
Updated:  6/23/2011
Emory Children's Center
mi
from
Atlanta, GA
Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis
Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis
Status: Enrolling
Updated: 6/23/2011
Emory Children's Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Birmingham Gastroenterology Associates P.C.
mi
from
Birmingham, AL
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Birmingham Gastroenterology Associates P.C.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Digestive Health Specialists of the Southeast
mi
from
Dothan, AL
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Digestive Health Specialists of the Southeast
mi
from
Dothan, AL
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Desert Sun Gastroenterology
mi
from
Tucson, AZ
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Desert Sun Gastroenterology
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Rocky Mountain Gastroenterology Associates
mi
from
Thornton, CO
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Rocky Mountain Gastroenterology Associates
mi
from
Thornton, CO
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Litchfield County Gastroenterology and Associates
mi
from
Torrington, CT
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Litchfield County Gastroenterology and Associates
mi
from
Torrington, CT
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Center for Gastrointestinal Disorders
mi
from
Hollywood, FL
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Center for Gastrointestinal Disorders
mi
from
Hollywood, FL
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Gastroenterology Group of Naples
mi
from
Naples, FL
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Gastroenterology Group of Naples
mi
from
Naples, FL
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Advanced Pain Care Clinic
mi
from
Evansville, IN
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Advanced Pain Care Clinic
mi
from
Evansville, IN
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Center for Digestive & Liver Diseases Inc.
mi
from
Mexico, MO
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Center for Digestive & Liver Diseases Inc.
mi
from
Mexico, MO
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
South Jersey Gastroenterology
mi
from
Marlton, NJ
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
South Jersey Gastroenterology
mi
from
Marlton, NJ
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Synergy First Medical
mi
from
Brooklyn, NY
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Synergy First Medical
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Research Associates of New York (RANY)
mi
from
New York, NY
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Research Associates of New York (RANY)
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Memphis Gastroenterology Group
mi
from
Germantown, TN
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Memphis Gastroenterology Group
mi
from
Germantown, TN
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
The First Clinic
mi
from
Nashville, TN
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
The First Clinic
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
South Texas Research Alliance
mi
from
Laredo, TX
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
South Texas Research Alliance
mi
from
Laredo, TX
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Wisconsin Center for Advanced Research
mi
from
Milwaukee, WI
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Wisconsin Center for Advanced Research
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Clinical Research of South Florida
mi
from
Boynton Beach, FL
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Clinical Research of South Florida
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Digestive Research Associates
mi
from
Newman, GA
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Digestive Research Associates
mi
from
Newman, GA
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Gastrointestinal Associates, P.A.
mi
from
Jackson, MS
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Gastrointestinal Associates, P.A.
mi
from
Jackson, MS
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Cleveland Clinic
mi
from
Cleveland, OH
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated:  7/6/2011
Gastroenterology & Hepatology Clinic
mi
from
Abbotsford,
Efficacy and Safety Study of MAX-002 Suppository Versus Placebo in Mild to Moderate Ulcerative Proctitis
A Multicenter, Double-blind, Controlled, Randomized, Parallel Group Comparison Phase IIIa Treatment Investigation on the Efficacy and Safety of MAX-002 Suppository Versus Placebo and Active Medicine in Mild to Moderate Ulcerative Proctitis
Status: Enrolling
Updated: 7/6/2011
Gastroenterology & Hepatology Clinic
mi
from
Abbotsford,
Click here to add this to my saved trials
Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance
Comparison of Study Method Versus Conventional Method for Performing Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance
Status: Enrolling
Updated:  7/10/2011
Sacramento VA Medical Center
mi
from
Mather, CA
Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance
Comparison of Study Method Versus Conventional Method for Performing Unsedated Colonoscopy for Colorectal Cancer Screening and Surveillance
Status: Enrolling
Updated: 7/10/2011
Sacramento VA Medical Center
mi
from
Mather, CA
Click here to add this to my saved trials
Combined Chromoendoscopy and Water Method for Screening Colonoscopy
Randomized Controlled Trial (RCT) to Compare Adenoma Detection Rate of Combined Chromoendoscopy (Indigo Carmine) With Water Infusion in Lieu of Air Insufflation (Water Method) vs. Water Method Alone in Screening Colonoscopy
Status: Enrolling
Updated:  7/10/2011
Sacramento VA Medical Center
mi
from
Mather, CA
Combined Chromoendoscopy and Water Method for Screening Colonoscopy
Randomized Controlled Trial (RCT) to Compare Adenoma Detection Rate of Combined Chromoendoscopy (Indigo Carmine) With Water Infusion in Lieu of Air Insufflation (Water Method) vs. Water Method Alone in Screening Colonoscopy
Status: Enrolling
Updated: 7/10/2011
Sacramento VA Medical Center
mi
from
Mather, CA
Click here to add this to my saved trials
Anti-inflammatory Treatment at the Onset of Necrotizing Enterocolitis (NEC) in Preterm Infants
Anti-inflammatory Treatment at the Onset of NEC in Preterm Infants- a Pilot Study
Status: Enrolling
Updated:  7/11/2011
University of Chicago Comer Children's Hospital
mi
from
Chicago, IL
Anti-inflammatory Treatment at the Onset of Necrotizing Enterocolitis (NEC) in Preterm Infants
Anti-inflammatory Treatment at the Onset of NEC in Preterm Infants- a Pilot Study
Status: Enrolling
Updated: 7/11/2011
University of Chicago Comer Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Anti-inflammatory Treatment at the Onset of Necrotizing Enterocolitis (NEC) in Preterm Infants
Anti-inflammatory Treatment at the Onset of NEC in Preterm Infants- a Pilot Study
Status: Enrolling
Updated:  7/11/2011
NorthShore University HealthSystem
mi
from
Evanston, IL
Anti-inflammatory Treatment at the Onset of Necrotizing Enterocolitis (NEC) in Preterm Infants
Anti-inflammatory Treatment at the Onset of NEC in Preterm Infants- a Pilot Study
Status: Enrolling
Updated: 7/11/2011
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Transition Study of Inflammatory Bowel Disease (IBD) Patients From Pediatric Gastroenterologist to Adult Gastroenterologist
Improving the Transition of Care From Pediatric GI to Adult GI for Patients With IBD: A Prospective Randomized Trial of a New Model
Status: Enrolling
Updated:  7/14/2011
The Vanderbilt Clinic
mi
from
Nashville, TN
Transition Study of Inflammatory Bowel Disease (IBD) Patients From Pediatric Gastroenterologist to Adult Gastroenterologist
Improving the Transition of Care From Pediatric GI to Adult GI for Patients With IBD: A Prospective Randomized Trial of a New Model
Status: Enrolling
Updated: 7/14/2011
The Vanderbilt Clinic
mi
from
Nashville, TN
Click here to add this to my saved trials
Transition Study of Inflammatory Bowel Disease (IBD) Patients From Pediatric Gastroenterologist to Adult Gastroenterologist
Improving the Transition of Care From Pediatric GI to Adult GI for Patients With IBD: A Prospective Randomized Trial of a New Model
Status: Enrolling
Updated:  7/14/2011
Vanderbilt Childrens Hospital/ Pediatric Gastroenterology Clinic
mi
from
Nashville, TN
Transition Study of Inflammatory Bowel Disease (IBD) Patients From Pediatric Gastroenterologist to Adult Gastroenterologist
Improving the Transition of Care From Pediatric GI to Adult GI for Patients With IBD: A Prospective Randomized Trial of a New Model
Status: Enrolling
Updated: 7/14/2011
Vanderbilt Childrens Hospital/ Pediatric Gastroenterology Clinic
mi
from
Nashville, TN
Click here to add this to my saved trials
Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
Decisional Influences and IBD Patients' Medication Use
Status: Enrolling
Updated:  7/14/2011
Inflammatory Bowel Disease Clinic c/o Divison of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, Vanderbilt University
mi
from
Nashville, TN
Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
Decisional Influences and IBD Patients' Medication Use
Status: Enrolling
Updated: 7/14/2011
Inflammatory Bowel Disease Clinic c/o Divison of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Look at Benefit of Surgical Drainage Before Beginning Medical Therapy for Crohns Perianal Fistulas
A Prospective Multicenter Trial Evaluating the Benefit of INitial Surgically Established Drainage Prior to Medical Therapy for the Treatment for Crohn's Perianal Fistulas
Status: Enrolling
Updated:  7/14/2011
Vanderbilt University Medical Center
mi
from
Nashville, TN
Study to Look at Benefit of Surgical Drainage Before Beginning Medical Therapy for Crohns Perianal Fistulas
A Prospective Multicenter Trial Evaluating the Benefit of INitial Surgically Established Drainage Prior to Medical Therapy for the Treatment for Crohn's Perianal Fistulas
Status: Enrolling
Updated: 7/14/2011
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Vitamin D and Functional Outcomes After Total Hip Arthroplasty (THA)
The Effect of Serum Vitamin D Level and the Short Term Functional Outcomes After Total Hip Arthroplasty
Status: Enrolling
Updated:  7/18/2011
Hospital for Special Surgery
mi
from
New York, NY
Vitamin D and Functional Outcomes After Total Hip Arthroplasty (THA)
The Effect of Serum Vitamin D Level and the Short Term Functional Outcomes After Total Hip Arthroplasty
Status: Enrolling
Updated: 7/18/2011
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Correlation Between Wound Volume and Depth of Decubitus Ulcers And Resting Energy Expenditure
Correlation Between Wound Volume and Depth of Decubitus Ulcers And Resting Energy Expenditure
Status: Enrolling
Updated:  7/19/2011
Saint Elizabeth Regional Burn and Wound Center
mi
from
Lincoln, NE
Correlation Between Wound Volume and Depth of Decubitus Ulcers And Resting Energy Expenditure
Correlation Between Wound Volume and Depth of Decubitus Ulcers And Resting Energy Expenditure
Status: Enrolling
Updated: 7/19/2011
Saint Elizabeth Regional Burn and Wound Center
mi
from
Lincoln, NE
Click here to add this to my saved trials